Sarita Rajender Potlapally

发表

Selective ATP competitive leads of CDK4: Discovery by 3D-QSAR pharmacophore mapping and molecular docking approach

Rohini Rondla, Lavanya Souda PadmaRao, Vishwanath Ramatenki, 2017, Comput. Biol. Chem..

Identification of novel anti cancer agents by applying insilico methods for inhibition of TSPO protein

Sree Kanth Sivan, Sarita Rajender Potlapally, Manan Bhargavi, 2017, Comput. Biol. Chem..

Identification and optimisation of novel selective inhibitors against human regulator of G protein signalling 2 (RGS2) protein for type 2 diabetes mellitus: an in silico approach

Sarita Rajender Potlapally, Revanth Bathula, Goverdhan Lanka, 2021, Int. J. Comput. Biol. Drug Des..

Azolium analogues as CDK4 inhibitors: Pharmacophore modeling, 3D QSAR study and new lead drug discovery

Sarita Rajender Potlapally, Thirupathi Mukkera, Uma Vuruputuri, 2017 .

Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy

Sarita Rajender Potlapally, Uma Vuruputuri, Ramakrishna Dumpati, 2017, Applied Biochemistry and Biotechnology.

Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery–a structure-based approach

Sarita Rajender Potlapally, Uma Vuruputuri, Ramakrishna Dumpati, 2017, Journal of chemical biology.

Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer

Sarita Rajender Potlapally, Uma Vuruputuri, Ramakrishna Dumpati, 2015, Journal of receptor and signal transduction research.

Targeting tribbles homolog 3 (TRIB3) protein against type 2 diabetes for the identification of potential inhibitors by in silico screening

Sarita Rajender Potlapally, M. Bhargavi, G. Lanka, 2022, Journal of the Indian Chemical Society.

Identification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein

Sarita Rajender Potlapally, Vasavi Malkhed, Uma Vuruputuri, 2014, Journal of biomolecular structure & dynamics.

Macromolecular structure and interaction studies of SigF and Usfx in Mycobacterium tuberculosis

Sarita Rajender Potlapally, Vasavi Malkhed, Uma Vuruputuri, 2014, Journal of receptor and signal transduction research.

Identification of new anti-cancer agents against CENTERIN: Structure-Based Virtual Screening, AutoDock and Binding free energy studies

Sarita Rajender Potlapally, G. Lanka, Revanth Bathula, 2022, Journal of Molecular Structure.

Structural insight into PRMT5 inhibitors through amalgamating pharmacophore-based virtual screening, ADME toxicity, and binding energy studies to identify new inhibitors by molecular docking

Sarita Rajender Potlapally, S. Sivan, G. Lanka, 2022, Structural Chemistry.

Structure-based identification of potential novel inhibitors targeting FAM3B (PANDER) causing type 2 diabetes mellitus through virtual screening

Sarita Rajender Potlapally, M. Bhargavi, G. Lanka, 2019, Journal of receptor and signal transduction research.

Homology modelling and virtual screening to explore potent inhibitors for MAP2K3 protein

Sarita Rajender Potlapally, S. S. Kanth, M. Bhargavi, 2020, Structural Chemistry.

Modeling of Alternate RNA Polymerase Sigma D Factor and Identification of Novel Inhibitors by Virtual Screening

Sarita Rajender Potlapally, Vasavi Malkhed, Uma Vuruputuri, 2012, Cellular and Molecular Bioengineering.

Modeling of Alternate RNA Polymerase Sigma D Factor and Identification of Novel Inhibitors by Virtual Screening

Sarita Rajender Potlapally, Vasavi Malkhed, Uma Vuruputuri, 2012 .